{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:34:52Z","timestamp":1794436492624,"version":"4.9.1"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82303116"],"award-info":[{"award-number":["No. 82303116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202301ZYTS047"],"award-info":[{"award-number":["YDZJ202301ZYTS047"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Science and Technology Capacity improvement Project of Jilin Province","award":["2022JC069"],"award-info":[{"award-number":["2022JC069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02275-z","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:51:31Z","timestamp":1749099091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Combination strategies of gut microbiota in cancer therapy through metabolic reprogramming and immune remodeling"],"prefix":"10.1186","volume":"23","author":[{"given":"Lixuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manshi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quezhu","family":"Danzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"2275_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/microorganisms8040483","volume":"8","author":"R Vemuri","year":"2020","unstructured":"Vemuri R, Shankar EM, Chieppa M, Eri R, Kavanagh K. Beyond Just Bacteria: Functional Biomes in the Gut Ecosystem Including Virome, Mycobiome. Archaeome and Helminths Microorganisms. 2020;8:483.","journal-title":"Archaeome and Helminths Microorganisms"},{"key":"2275_CR2","doi-asserted-by":"crossref","unstructured":"Zhu R, Lang T, Yan W, Zhu X, Huang X, Yin Q, Li Y. Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2021;8:2003542.","DOI":"10.1002\/advs.202003542"},{"key":"2275_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nature13312","volume":"511","author":"B Ghesqui\u00e8re","year":"2014","unstructured":"Ghesqui\u00e8re B, Wong BW, Kuchnio A, Carmeliet P. Metabolism of stromal and immune cells in health and disease. Nature. 2014;511:167\u201376.","journal-title":"Nature"},{"key":"2275_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20:1\u201321.","journal-title":"Mol Cancer"},{"key":"2275_CR5","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3390\/cancers15051588","volume":"15","author":"M Luu","year":"2023","unstructured":"Luu M, Sch\u00fctz B, Lauth M, Visekruna A. The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment. Cancers. 2023;15:1588.","journal-title":"Cancers"},{"key":"2275_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499:97\u2013101.","journal-title":"Nature"},{"key":"2275_CR7","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00726-017-2493-3","volume":"49","author":"R Lin","year":"2017","unstructured":"Lin R, Liu W, Piao M, Zhu H. A review of the relationship between the gut microbiota and amino acid metabolism. Amino Acids. 2017;49:2083\u201390.","journal-title":"Amino Acids"},{"key":"2275_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.exger.2014.03.024","volume":"56","author":"JAB Strickertsson","year":"2014","unstructured":"Strickertsson JAB, Desler C, Rasmussen LJ. Impact of bacterial infections on aging and cancer: impairment of DNA repair and mitochondrial function of host cells. Exp Gerontol. 2014;56:164\u201374.","journal-title":"Exp Gerontol"},{"key":"2275_CR9","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","DOI":"10.3322\/caac.21820"},{"key":"2275_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, Cheng Q, Luo P, Zhang Y, Han X. Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Ther. 2023;8:200.","journal-title":"Signal Transduct Target Ther"},{"key":"2275_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-021-03547-7","volume":"594","author":"MJ Yousefzadeh","year":"2021","unstructured":"Yousefzadeh MJ, Flores RR, Zhu Y, Schmiechen ZC, Brooks RW, Trussoni CE, Cui Y, Angelini L, Lee K-A, McGowan SJ, et al. An aged immune system drives senescence and ageing of solid organs. Nature. 2021;594:100\u20135.","journal-title":"Nature"},{"key":"2275_CR12","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre M-L, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science (New York, NY). 2015;350:1084\u20139.","journal-title":"Science (New York, NY)"},{"key":"2275_CR13","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CPM, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science (New York, NY). 2015;350:1079\u201384.","journal-title":"Science (New York, NY)"},{"key":"2275_CR14","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1126\/science.aax0701","volume":"369","author":"A Fluckiger","year":"2020","unstructured":"Fluckiger A, Daill\u00e8re R, Sassi M, Sixt BS, Liu P, Loos F, Richard C, Rabu C, Alou MT, Goubet A-G, et al. Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage. Science (New York, NY). 2020;369:936\u201342.","journal-title":"Science (New York, NY)"},{"key":"2275_CR15","doi-asserted-by":"crossref","unstructured":"Ting NL-N, Lau HC-H, Yu J. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes. Gut. 2022;71:1412\u20131425.","DOI":"10.1136\/gutjnl-2021-326264"},{"key":"2275_CR16","doi-asserted-by":"crossref","unstructured":"Colbert LE, Previs R, Medrano AYD, Eifel PJ, Jhingran A, Ramondetta L, Hahn SM, Jazaeri A, Frumovitz M, Schmeler K, et al. Rectal Microbiome Diversity Predicts Disease Response at Completion of Radiation Therapy for Squamous Cell Carcinoma of the Cervix. Int J Radiation Oncolo*Biol*Physics. 2017;99:S51.","DOI":"10.1016\/j.ijrobp.2017.06.129"},{"key":"2275_CR17","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/acsomega.0c04394","volume":"6","author":"Y Luo","year":"2021","unstructured":"Luo Y, Wang C-Z, Sawadogo R, Yuan J, Zeng J, Xu M, Tan T, Yuan C-S. 4-Vinylguaiacol, an Active Metabolite of Ferulic Acid by Enteric Microbiota and Probiotics, Possesses Significant Activities against Drug-Resistant Human Colorectal Cancer Cells. ACS Omega. 2021;6:4551\u201361.","journal-title":"ACS Omega"},{"key":"2275_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science (New York, NY). 2018;359:97\u2013103.","journal-title":"Science (New York, NY)"},{"key":"2275_CR19","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science (New York, NY). 2017;357:1156\u201360.","journal-title":"Science (New York, NY)"},{"key":"2275_CR20","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-19-0960","volume":"25","author":"M Reis Ferreira","year":"2019","unstructured":"Reis Ferreira M, Andreyev HJN, Mohammed K, Truelove L, Gowan SM, Li J, Gulliford SL, Marchesi JR, Dearnaley DP. Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 2019;25:6487\u2013500.","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"2275_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin J-M, Morrison RM, Deblasio RN, Menna C, Ding Q, Pagliano O, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science (New York, NY). 2021;371:595\u2013602.","journal-title":"Science (New York, NY)"},{"key":"2275_CR22","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41551-022-00886-2","volume":"6","author":"Y Yue","year":"2022","unstructured":"Yue Y, Xu J, Li Y, Cheng K, Feng Q, Ma X, Ma N, Zhang T, Wang X, Zhao X, Nie G. Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria. Nature Biomedical Engineering. 2022;6:898\u2013909.","journal-title":"Nature Biomedical Engineering"},{"key":"2275_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"2275_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fnut.2018.00044","volume":"5","author":"MR Casanova","year":"2018","unstructured":"Casanova MR, Azevedo-Silva J, Rodrigues LR, Preto A. Colorectal Cancer Cells Increase the Production of Short Chain Fatty Acids by Propionibacterium freudenreichii Impacting on Cancer Cells Survival. Front Nutr. 2018;5:44.","journal-title":"Front Nutr"},{"key":"2275_CR25","doi-asserted-by":"crossref","unstructured":"Zhao C, Dong H, Zhang Y, Li Y. Discovery of potential genes contributing to the biosynthesis of short-chain fatty acids and lactate in gut microbiota from systematic investigation in E. coli. NPJ biofilms and microbiomes. 2019;5:19.","DOI":"10.1038\/s41522-019-0092-7"},{"key":"2275_CR26","doi-asserted-by":"publisher","first-page":"e002305","DOI":"10.1136\/jitc-2020-002305","volume":"9","author":"H Deng","year":"2021","unstructured":"Deng H, Kan A, Lyu N, He M, Huang X, Qiao S, Li S, Lu W, Xie Q, Chen H, et al. Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma. J Immunother Cancer. 2021;9:e002305.","journal-title":"J Immunother Cancer"},{"key":"2275_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo M, Tsai C-H, Pucino V, Ho P-C, Mauro C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol. 2021;21:151\u201361.","journal-title":"Nat Rev Immunol"},{"key":"2275_CR28","first-page":"1348","volume":"9","author":"SM McNabney","year":"2017","unstructured":"McNabney SM, Henagan TM. Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer. Obesity and Insulin Resistance. Nutrients. 2017;9:1348.","journal-title":"Obesity and Insulin Resistance Nutrients"},{"key":"2275_CR29","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s12029-019-00329-3","volume":"51","author":"M Eslami","year":"2020","unstructured":"Eslami M, Sadrifar S, Karbalaei M, Keikha M, Kobyliak NM, Yousefi B. Importance of the Microbiota Inhibitory Mechanism on the Warburg Effect in Colorectal Cancer Cells. J Gastrointest Cancer. 2020;51:738\u201347.","journal-title":"J Gastrointest Cancer"},{"key":"2275_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","volume":"48","author":"DR Donohoe","year":"2012","unstructured":"Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell. 2012;48:612\u201326.","journal-title":"Mol Cell"},{"key":"2275_CR31","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nchembio.1060","volume":"8","author":"D Anastasiou","year":"2012","unstructured":"Anastasiou D, Yu Y, Israelsen WJ, Jiang J-K, Boxer MB, Hong BS, Tempel W, Dimov S, Shen M, Jha A, et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol. 2012;8:839\u201347.","journal-title":"Nat Chem Biol"},{"key":"2275_CR32","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1074\/mcp.RA118.000752","volume":"17","author":"Q Li","year":"2018","unstructured":"Li Q, Cao L, Tian Y, Zhang P, Ding C, Lu W, Jia C, Shao C, Liu W, Wang D, et al. Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming. Molecular & cellular proteomics: MCP. 2018;17:1531\u201345.","journal-title":"Molecular & cellular proteomics: MCP"},{"key":"2275_CR33","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","volume":"30","author":"EM P\u00e5lsson-McDermott","year":"2020","unstructured":"P\u00e5lsson-McDermott EM, O\u2019Neill LAJ. Targeting immunometabolism as an anti-inflammatory strategy. Cell Res. 2020;30:300\u201314.","journal-title":"Cell Res"},{"key":"2275_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.coi.2017.04.010","volume":"46","author":"CM Weyand","year":"2017","unstructured":"Weyand CM, Zeisbrich M, Goronzy JJ. Metabolic signatures of T-cells and macrophages in rheumatoid arthritis. Curr Opin Immunol. 2017;46:112\u201320.","journal-title":"Curr Opin Immunol"},{"key":"2275_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.omto.2023.08.010","volume":"30","author":"J Yi","year":"2023","unstructured":"Yi J, Lin P, Li Q, Zhang A, Kong X. A new strategy for treating colorectal cancer: Regulating the influence of intestinal flora and oncolytic virus on interferon. Molecular Therapy Oncolytics. 2023;30:254\u201374.","journal-title":"Molecular Therapy Oncolytics"},{"key":"2275_CR36","doi-asserted-by":"publisher","first-page":"2207366","DOI":"10.1002\/advs.202207366","volume":"10","author":"Q Yang","year":"2023","unstructured":"Yang Q, Wang B, Zheng Q, Li H, Meng X, Zhou F, Zhang L. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy. Advanced Science. 2023;10:2207366.","journal-title":"Advanced Science"},{"key":"2275_CR37","first-page":"4439","volume":"16","author":"T Xiao","year":"2018","unstructured":"Xiao T, Wu S, Yan C, Zhao C, Jin H, Yan N, Xu J, Wu Y, Li C, Shao Q, Xia S. Butyrate upregulates the TLR4 expression and the phosphorylation of MAPKs and NK-\u03baB in colon cancer cell in vitro. Oncol Lett. 2018;16:4439\u201347.","journal-title":"Oncol Lett"},{"key":"2275_CR38","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.chom.2023.10.005","volume":"31","author":"X Huang","year":"2023","unstructured":"Huang X, Hu M, Sun T, Li J, Zhou Y, Yan Y, Xuan B, Wang J, Xiong H, Ji L, et al. Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts. Cell Host Microbe. 2023;31:1930-1943.e1934.","journal-title":"Cell Host Microbe"},{"key":"2275_CR39","doi-asserted-by":"publisher","first-page":"e0186334","DOI":"10.1371\/journal.pone.0186334","volume":"12","author":"M Thirunavukkarasan","year":"2017","unstructured":"Thirunavukkarasan M, Wang C, Rao A, Hind T, Teo YR. Siddiquee AA-M, Goghari MAI, Kumar AP, Herr DR. Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells. PLoS ONE. 2017;12:e0186334.","journal-title":"PLoS ONE"},{"key":"2275_CR40","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","volume":"11","author":"C Coutzac","year":"2020","unstructured":"Coutzac C, Jouniaux J-M, Paci A, Schmidt J, Mallardo D, Seck A, Asvatourian V, Cassard L, Saulnier P, Lacroix L, et al. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nat Commun. 2020;11:2168.","journal-title":"Nat Commun"},{"key":"2275_CR41","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Ch\u00e1vez-Talavera","year":"2017","unstructured":"Ch\u00e1vez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. Gastroenterology. 2017;152:1679-1694.e1673.","journal-title":"Gastroenterology"},{"key":"2275_CR42","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","volume":"7","author":"TM Loo","year":"2017","unstructured":"Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, Nakajima-Takagi Y, Iwama A, Koga T, Sugimoto Y, et al. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity. Cancer Discov. 2017;7:522\u201338.","journal-title":"Cancer Discov"},{"key":"2275_CR43","doi-asserted-by":"crossref","unstructured":"Li T-T, Chen X, Huo D, Arifuzzaman M, Qiao S, Jin W-B, Shi H, Li XV, Consortium JLCB, Iliev ID, et al. Microbiota metabolism of intestinal amino acids impacts host nutrient homeostasis and physiology. Cell Host Microbe. 2024;32:661\u2013675.e610.","DOI":"10.1016\/j.chom.2024.04.004"},{"key":"2275_CR44","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.3390\/ijms22126262","volume":"22","author":"M Nenkov","year":"2021","unstructured":"Nenkov M, Ma Y, Ga\u00dfler N, Chen Y. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy. Int J Mol Sci. 2021;22:6262.","journal-title":"Int J Mol Sci"},{"key":"2275_CR45","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41586-018-0701-2","volume":"563","author":"SJF Cronin","year":"2018","unstructured":"Cronin SJF, Seehus C, Weidinger A, Talbot S, Reissig S, Seifert M, Pierson Y, McNeill E, Longhi MS, Turnes BL, et al. The metabolite BH4 controls T cell proliferation in autoimmunity and cancer. Nature. 2018;563:564\u20138.","journal-title":"Nature"},{"key":"2275_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s40425-019-0650-9","volume":"7","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Wang T, Tu X, Huang Y, Zhang H, Tan D, Jiang W, Cai S, Zhao P, Song R, et al. Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma. J Immunother Cancer. 2019;7:193.","journal-title":"J Immunother Cancer"},{"key":"2275_CR47","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","volume":"41","author":"M Venkatesh","year":"2014","unstructured":"Venkatesh M, Mukherjee S, Wang H, Li H, Sun K, Benechet AP, Qiu Z, Maher L, Redinbo MR, Phillips RS, et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity. 2014;41:296\u2013310.","journal-title":"Immunity"},{"key":"2275_CR48","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.3390\/ijms22095005","volume":"22","author":"I Yusufu","year":"2021","unstructured":"Yusufu I, Ding K, Smith K, Wankhade UD, Sahay B, Patterson GT, Pacholczyk R, Adusumilli S, Hamrick MW, Hill WD, et al. A Tryptophan-Deficient Diet Induces Gut Microbiota Dysbiosis and Increases Systemic Inflammation in Aged Mice. Int J Mol Sci. 2021;22:5005.","journal-title":"Int J Mol Sci"},{"key":"2275_CR49","first-page":"6006","volume":"7","author":"F Huang","year":"2014","unstructured":"Huang F, Zhao Y, Zhao J, Wu S, Jiang Y, Ma H, Zhang T. Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer. Int J Clin Exp Pathol. 2014;7:6006\u201314.","journal-title":"Int J Clin Exp Pathol"},{"key":"2275_CR50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4331\/wjbc.v6.i4.281","volume":"6","author":"E Ananieva","year":"2015","unstructured":"Ananieva E. Targeting amino acid metabolism in cancer growth and anti-tumor immune response. World J Biol Chem. 2015;6:281\u20139.","journal-title":"World J Biol Chem"},{"key":"2275_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1053\/j.gastro.2011.05.035","volume":"141","author":"N Steck","year":"2011","unstructured":"Steck N, Hoffmann M, Sava IG, Kim SC, Hahne H, Tonkonogy SL, Mair K, Krueger D, Pruteanu M, Shanahan F, et al. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology. 2011;141:959\u201371.","journal-title":"Gastroenterology"},{"key":"2275_CR52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.chom.2014.02.007","volume":"15","author":"CL Sears","year":"2014","unstructured":"Sears CL, Garrett WS. Microbes, Microbiota, and Colon Cancer. Cell Host Microbe. 2014;15:317\u201328.","journal-title":"Cell Host Microbe"},{"key":"2275_CR53","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.7150\/thno.56747","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Qi H, Liu Y, Duan C, Liu X, Xia T, Chen D, Piao H-L, Liu H-X. The double-edged roles of ROS in cancer prevention and therapy. Theranostics. 2021;11:4839\u201357.","journal-title":"Theranostics"},{"key":"2275_CR54","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ccell.2019.12.012","volume":"37","author":"EC Cheung","year":"2020","unstructured":"Cheung EC, DeNicola GM, Nixon C, Blyth K, Labuschagne CF, Tuveson DA, Vousden KH. Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer. Cancer Cell. 2020;37:168-182.e164.","journal-title":"Cancer Cell"},{"key":"2275_CR55","doi-asserted-by":"publisher","first-page":"101772","DOI":"10.1016\/j.redox.2020.101772","volume":"38","author":"BD Paul","year":"2021","unstructured":"Paul BD, Snyder SH, Kashfi K. Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics. Redox Biol. 2021;38:101772.","journal-title":"Redox Biol"},{"key":"2275_CR56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cmet.2016.06.013","volume":"24","author":"F De Vadder","year":"2016","unstructured":"De Vadder F, Kovatcheva-Datchary P, Zitoun C, Duchampt A, B\u00e4ckhed F, Mithieux G. Microbiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis. Cell Metab. 2016;24:151\u20137.","journal-title":"Cell Metab"},{"key":"2275_CR57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/gutjnl-2018-316155","volume":"68","author":"Y Heianza","year":"2019","unstructured":"Heianza Y, Sun D, Li X, DiDonato JA, Bray GA, Sacks FM, Qi L. Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial. Gut. 2019;68:263\u201370.","journal-title":"Gut"},{"key":"2275_CR58","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186:243\u201378.","journal-title":"Cell"},{"key":"2275_CR59","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","volume":"185","author":"AB Dohlman","year":"2022","unstructured":"Dohlman AB, Klug J, Mesko M, Gao IH, Lipkin SM, Shen X, Iliev ID. A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell. 2022;185:3807-3822.e3812.","journal-title":"Cell"},{"key":"2275_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2023.127440","volume":"274","author":"T Liu","year":"2023","unstructured":"Liu T, Du D, Zhao R, Xie Q, Dong Z. Gut microbes influence the development of central nervous system disorders through epigenetic inheritance. Microbiol Res. 2023;274: 127440.","journal-title":"Microbiol Res"},{"key":"2275_CR61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"J-P Copp\u00e9","year":"2010","unstructured":"Copp\u00e9 J-P, Desprez P-Y, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99\u2013118.","journal-title":"Annu Rev Pathol"},{"key":"2275_CR62","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2020","unstructured":"Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer. 2020;20:89\u2013106.","journal-title":"Nat Rev Cancer"},{"key":"2275_CR63","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.freeradbiomed.2015.05.005","volume":"85","author":"M Pinto","year":"2015","unstructured":"Pinto M, Moraes CT. Mechanisms linking mtDNA damage and aging. Free Radical Biol Med. 2015;85:250\u20138.","journal-title":"Free Radical Biol Med"},{"key":"2275_CR64","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1038\/onc.2013.467","volume":"33","author":"M Guha","year":"2014","unstructured":"Guha M, Srinivasan S, Ruthel G, Kashina AK, Carstens RP, Mendoza A, Khanna C, Van Winkle T, Avadhani NG. Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells. Oncogene. 2014;33:5238\u201350.","journal-title":"Oncogene"},{"key":"2275_CR65","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semcancer.2024.07.004","volume":"104\u2013105","author":"Y Xu","year":"2024","unstructured":"Xu Y, He C, Xi Y, Zhang Y, Bai Y. Gut microbiota and immunosenescence in cancer. Semin Cancer Biol. 2024;104\u2013105:32\u201345.","journal-title":"Semin Cancer Biol"},{"key":"2275_CR66","doi-asserted-by":"crossref","unstructured":"Madison AA, Burd CE, Andridge R, Wilson SJ, Bailey MT, Belury MA, Spakowicz DJ, Malarkey WB, Kiecolt-Glaser JK. Gut Microbiota Richness and Diversity Track With T Cell Aging in Healthy Adults. J Gerontol A Biol Sci Med Sci. 2024;79:glad276.","DOI":"10.1093\/gerona\/glad276"},{"key":"2275_CR67","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","volume":"6","author":"Q Duan","year":"2020","unstructured":"Duan Q, Zhang H, Zheng J, Zhang L. Turning Cold into Hot: Firing up the Tumor Microenvironment. Trends in Cancer. 2020;6:605\u201318.","journal-title":"Trends in Cancer"},{"key":"2275_CR68","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, et al. Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack. Immunity. 2015;42:344\u201355.","journal-title":"Immunity"},{"key":"2275_CR69","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.devcel.2020.06.018","volume":"54","author":"F Li","year":"2020","unstructured":"Li F, Simon MC. Cancer Cells Don\u2019t Live Alone: Metabolic Communication within Tumor Microenvironments. Dev Cell. 2020;54:183\u201395.","journal-title":"Dev Cell"},{"key":"2275_CR70","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/gutjnl-2020-323426","volume":"71","author":"W Si","year":"2022","unstructured":"Si W, Liang H, Bugno J, Xu Q, Ding X, Yang K, Fu Y, Weichselbaum RR, Zhao X, Wang L. Lactobacillus rhamnosus GG induces cGAS\/STING- dependent type I interferon and improves response to immune checkpoint blockade. Gut. 2022;71:521\u201333.","journal-title":"Gut"},{"key":"2275_CR71","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, Paik S, Stagg J, Groves RA, Gallo M, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 2020;369:1481\u20139.","journal-title":"Science"},{"key":"2275_CR72","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41586-023-06026-3","volume":"617","author":"JS Park","year":"2023","unstructured":"Park JS, Gazzaniga FS, Wu M, Luthens AK, Gillis J, Zheng W, LaFleur MW, Johnson SB, Morad G, Park EM, et al. Targeting PD-L2\u2013RGMb overcomes microbiome-related immunotherapy resistance. Nature. 2023;617:377\u201385.","journal-title":"Nature"},{"issue":"e135597","key":"2275_CR73","doi-asserted-by":"publisher","first-page":"135597","DOI":"10.1172\/jci.insight.135597","volume":"5","author":"CA Bessell","year":"2020","unstructured":"Bessell CA, Isser A, Havel JJ, Lee S, Bell DR, Hickey JW, Chaisawangwong W, Glick Bieler J, Srivastava R, Kuo F, et al. Commensal bacteria stimulate antitumor responses via T cell cross-reactivity. JCI insight. 2020;5(e135597):135597.","journal-title":"JCI insight"},{"key":"2275_CR74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13045-016-0381-z","volume":"10","author":"X Liu","year":"2017","unstructured":"Liu X, Kwon H, Li Z, Fu Y-X. Is CD47 an innate immune checkpoint for tumor evasion? J Hematol Oncol. 2017;10:12.","journal-title":"J Hematol Oncol"},{"key":"2275_CR75","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrc3171","volume":"12","author":"MP Chao","year":"2011","unstructured":"Chao MP, Majeti R, Weissman IL. Programmed cell removal: a new obstacle in the road to developing cancer. Nat Rev Cancer. 2011;12:58\u201367.","journal-title":"Nat Rev Cancer"},{"key":"2275_CR76","doi-asserted-by":"publisher","first-page":"e20192282","DOI":"10.1084\/jem.20192282","volume":"217","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zheng W, Yang K, Harris KG, Ni K, Xue L, Lin W, Chang EB, Weichselbaum RR, Fu Y-X. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J Exp Med. 2020;217:e20192282.","journal-title":"J Exp Med"},{"key":"2275_CR77","doi-asserted-by":"publisher","first-page":"1362133","DOI":"10.3389\/fimmu.2024.1362133","volume":"15","author":"P-F Zhang","year":"2024","unstructured":"Zhang P-F, Xie D. Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope? Front Immunol. 2024;15:1362133.","journal-title":"Front Immunol"},{"key":"2275_CR78","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","volume":"29","author":"CK Stein-Thoeringer","year":"2023","unstructured":"Stein-Thoeringer CK, Saini NY, Zamir E, Blumenberg V, Schubert M-L, Mor U, Fante MA, Schmidt S, Hayase E, Hayase T, et al. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nat Med. 2023;29:906\u201316.","journal-title":"Nat Med"},{"key":"2275_CR79","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41591-022-01702-9","volume":"28","author":"M Smith","year":"2022","unstructured":"Smith M, Dai A, Ghilardi G, Amelsberg KV, Devlin SM, Pajarillo R, Slingerland JB, Beghi S, Herrera PS, Giardina P, et al. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat Med. 2022;28:713\u201323.","journal-title":"Nat Med"},{"key":"2275_CR80","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1038\/s41467-022-32960-3","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Li J, Ni F, Yang Z, Gui X, Bao Z, Zhao H, Wei G, Wang Y, Zhang M, et al. CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies. Nat Commun. 2022;13:5313.","journal-title":"Nat Commun"},{"key":"2275_CR81","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A, Klein M, Wempe A, Leister H, Raifer H, et al. Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021;12:4077.","journal-title":"Nat Commun"},{"issue":"e94952","key":"2275_CR82","doi-asserted-by":"publisher","first-page":"94952","DOI":"10.1172\/jci.insight.94952","volume":"3","author":"M Uribe-Herranz","year":"2018","unstructured":"Uribe-Herranz M, Bittinger K, Rafail S, Guedan S, Pierini S, Tanes C, Ganetsky A, Morgan MA, Gill S, Tanyi JL, et al. Gut microbiota modulates adoptive cell therapy via CD8\u03b1 dendritic cells and IL-12. JCI insight. 2018;3(e94952):94952.","journal-title":"JCI insight"},{"key":"2275_CR83","doi-asserted-by":"publisher","first-page":"108103","DOI":"10.1016\/j.pharmthera.2021.108103","volume":"236","author":"S Feola","year":"2022","unstructured":"Feola S, Russo S, Yl\u00f6sm\u00e4ki E, Cerullo V. Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment. Pharmacol Ther. 2022;236:108103.","journal-title":"Pharmacol Ther"},{"key":"2275_CR84","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41392-023-01603-4","volume":"8","author":"B Cui","year":"2023","unstructured":"Cui B, Song L, Wang Q, Li K, He Q, Wu X, Gao F, Liu M, An C, Gao Q, et al. Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors. Signal Transduct Target Ther. 2023;8:366.","journal-title":"Signal Transduct Target Ther"},{"key":"2275_CR85","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3390\/v15081645","volume":"15","author":"P Muthukutty","year":"2023","unstructured":"Muthukutty P, Yoo SY. Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective. Viruses. 2023;15:1645.","journal-title":"Viruses"},{"key":"2275_CR86","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1158\/1535-7163.MCT-20-0405","volume":"20","author":"S-I Kim","year":"2021","unstructured":"Kim S-I, Park AK, Chaurasiya S, Kang S, Lu J, Yang A, Sivanandam V, Zhang Z, Woo Y, Priceman SJ, et al. Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity. Mol Cancer Ther. 2021;20:173\u201382.","journal-title":"Mol Cancer Ther"},{"key":"2275_CR87","doi-asserted-by":"crossref","unstructured":"Tripodi L, Feola S, Granata I, Whalley T, Passariello M, Capasso C, Coluccino L, Vitale M, Scalia G, Gentile L, et al. Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma. iScience. 2023;26:107668.","DOI":"10.1016\/j.isci.2023.107668"},{"key":"2275_CR88","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1007\/s10620-024-08346-4","volume":"69","author":"X Chen","year":"2024","unstructured":"Chen X, Wang G, Qin L, Hu B, Li J. Intestinal Microbiota Modulates the Antitumor Effect of Oncolytic Virus Vaccines in Colorectal Cancer. Dig Dis Sci. 2024;69:1228\u201341.","journal-title":"Dig Dis Sci"},{"key":"2275_CR89","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1586\/erv.10.174","volume":"10","author":"C Bode","year":"2011","unstructured":"Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines. 2011;10:499\u2013511.","journal-title":"Expert Rev Vaccines"},{"key":"2275_CR90","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science (New York, NY). 2013;342:967\u201370.","journal-title":"Science (New York, NY)"},{"key":"2275_CR91","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3892\/ijo.2015.3173","volume":"47","author":"C-Z Wang","year":"2015","unstructured":"Wang C-Z, Zhang C-F, Chen L, Anderson S, Lu F, Yuan C-S. Colon cancer chemopreventive effects of baicalein, an active enteric microbiome metabolite from baicalin. Int J Oncol. 2015;47:1749\u201358.","journal-title":"Int J Oncol"},{"key":"2275_CR92","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1053\/j.gastro.2023.08.052","volume":"165","author":"H Gou","year":"2023","unstructured":"Gou H, Su H, Liu D, Wong CC, Shang H, Fang Y, Zeng X, Chen H, Li Y, Huang Z, et al. Traditional Medicine Pien Tze Huang Suppresses Colorectal Tumorigenesis Through Restoring Gut Microbiota and Metabolites. Gastroenterology. 2023;165:1404\u201319.","journal-title":"Gastroenterology"},{"key":"2275_CR93","doi-asserted-by":"publisher","first-page":"135361","DOI":"10.1016\/j.foodchem.2022.135361","volume":"410","author":"B Han","year":"2023","unstructured":"Han B, Zhai Y, Li X, Zhao H, Sun C, Zeng Y, Zhang W, Lu J, Kai G. Total flavonoids of Tetrastigma hemsleyanum Diels et Gilg inhibits colorectal tumor growth by modulating gut microbiota and metabolites. Food Chem. 2023;410:135361.","journal-title":"Food Chem"},{"key":"2275_CR94","doi-asserted-by":"publisher","first-page":"609992","DOI":"10.3389\/fphar.2021.609992","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang X, Li J, Zhang Y, Guo Y, Chang Q, Chen L, Wang Y, Wang S, Song Y, et al. Sini Decoction Ameliorates Colorectal Cancer and Modulates the Composition of Gut Microbiota in Mice. Front Pharmacol. 2021;12:609992.","journal-title":"Front Pharmacol"},{"key":"2275_CR95","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13020-022-00667-8","volume":"17","author":"YL Lin","year":"2022","unstructured":"Lin YL, Huang G, Khan I, Su L, Xia W, Law BYK, Wong VKW, Wu Q, Wang J, Leong WK, Hsiao WLW. Poria cocos polysaccharides exert prebiotic function to attenuate the adverse effects and improve the therapeutic outcome of 5-FU in ApcMin\/+ mice. Chinese Medicine. 2022;17:116.","journal-title":"Chinese Medicine"},{"key":"2275_CR96","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/gutjnl-2020-321031","volume":"71","author":"J Huang","year":"2022","unstructured":"Huang J, Liu D, Wang Y, Liu L, Li J, Yuan J, Jiang Z, Jiang Z, Hsiao WW, Liu H, et al. Ginseng polysaccharides alter the gut microbiota and kynurenine\/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1\/programmed cell death ligand 1 (anti-PD-1\/PD-L1) immunotherapy. Gut. 2022;71:734\u201345.","journal-title":"Gut"},{"key":"2275_CR97","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41419-019-1638-6","volume":"10","author":"J Lv","year":"2019","unstructured":"Lv J, Jia Y, Li J, Kuai W, Li Y, Guo F, Xu X, Zhao Z, Lv J, Li Z. Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment. Cell Death Dis. 2019;10:415.","journal-title":"Cell Death Dis"},{"key":"2275_CR98","doi-asserted-by":"publisher","first-page":"14554","DOI":"10.1038\/srep14554","volume":"5","author":"P Lehouritis","year":"2015","unstructured":"Lehouritis P, Cummins J, Stanton M, Murphy CT, McCarthy FO, Reid G, Urbaniak C, Byrne WL, Tangney M. Local bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep. 2015;5:14554.","journal-title":"Sci Rep"},{"key":"2275_CR99","doi-asserted-by":"crossref","unstructured":"Scott TA, Quintaneiro LM, Norvaisas P, Lui PP, Wilson MP, Leung K-Y, Herrera-Dominguez L, Sudiwala S, Pessia A, Clayton PT, et al. Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C.\u00a0elegans. Cell. 201;169:442\u2013456.e418.","DOI":"10.1016\/j.cell.2017.03.040"},{"key":"2275_CR100","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","volume":"45","author":"R Daill\u00e8re","year":"2016","unstructured":"Daill\u00e8re R, V\u00e9tizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C, Lepage P, Roberti MP, et al. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity. 2016;45:931\u201343.","journal-title":"Immunity"},{"key":"2275_CR101","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1172\/JCI32205","volume":"117","author":"CM Paulos","year":"2007","unstructured":"Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, Palmer DC, Boni A, Muranski P, Yu Z, et al. Microbial translocation augments the function of adoptively transferred self\/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Investig. 2007;117:2197\u2013204.","journal-title":"J Clin Investig"},{"key":"2275_CR102","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.ccell.2021.07.002","volume":"39","author":"SL Shiao","year":"2021","unstructured":"Shiao SL, Kershaw KM, Limon JJ, You S, Yoon J, Ko EY, Guarnerio J, Potdar AA, McGovern DPB, Bose S, et al. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy. Cancer Cell. 2021;39:1202-1213.e1206.","journal-title":"Cancer Cell"},{"key":"2275_CR103","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40168-015-0094-5","volume":"3","author":"JR Marchesi","year":"2015","unstructured":"Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome. 2015;3:31.","journal-title":"Microbiome"},{"key":"2275_CR104","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","volume":"22","author":"MR Fernandes","year":"2022","unstructured":"Fernandes MR, Aggarwal P, Costa RGF, Cole AM, Trinchieri G. Targeting the gut microbiota for cancer therapy. Nat Rev Cancer. 2022;22:703\u201322.","journal-title":"Nat Rev Cancer"},{"key":"2275_CR105","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre M-L, Luke JJ, Gajewski TF. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science (New York, NY). 2018;359:104\u20138.","journal-title":"Science (New York, NY)"},{"key":"2275_CR106","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science (New York, NY). 2018;359:91\u20137.","journal-title":"Science (New York, NY)"},{"key":"2275_CR107","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, Adler K, Dick-Necula D, Raskin S, Bloch N, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science (New York, NY). 2021;371:602\u20139.","journal-title":"Science (New York, NY)"},{"key":"2275_CR108","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2020-321153","volume":"69","author":"WY Cheng","year":"2020","unstructured":"Cheng WY, Wu C-Y, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut. 2020;69:1867\u201376.","journal-title":"Gut"},{"key":"2275_CR109","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1073\/pnas.1712901115","volume":"115","author":"F Wang","year":"2018","unstructured":"Wang F, Yin Q, Chen L, Davis MM. Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade. Proc Natl Acad Sci USA. 2018;115:157\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2275_CR110","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.blre.2018.11.002","volume":"34","author":"JN Brudno","year":"2019","unstructured":"Brudno JN, Kochenderfer JN. Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management. Blood Rev. 2019;34:45\u201355.","journal-title":"Blood Rev"},{"key":"2275_CR111","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13876","volume":"10","author":"S Sitthirak","year":"2022","unstructured":"Sitthirak S, Suksawat M, Phetcharaburanin J, Wangwiwatsin A, Klanrit P, Namwat N, Khuntikeo N, Titapun A, Jarearnrat A, Sangkhamanon S, Loilome W. Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. PeerJ. 2022;10: e13876.","journal-title":"PeerJ"},{"key":"2275_CR112","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","volume":"39","author":"N Cullin","year":"2021","unstructured":"Cullin N, Azevedo Antunes C, Straussman R, Stein-Thoeringer CK, Elinav E. Microbiome and Cancer. Cancer Cell. 2021;39:1317\u201341.","journal-title":"Cancer Cell"},{"key":"2275_CR113","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"Wong CC, Yu J. Gut microbiota in colorectal cancer development and therapy. Nat Rev Clin Oncol. 2023;20:429\u201352.","journal-title":"Nat Rev Clin Oncol"},{"key":"2275_CR114","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1159\/000480005","volume":"42","author":"H Mi","year":"2017","unstructured":"Mi H, Dong Y, Zhang B, Wang H, Peter CCK, Gao P, Fu H, Gao Y. Bifidobacterium Infantis Ameliorates Chemotherapy-Induced Intestinal Mucositis Via Regulating T Cell Immunity in Colorectal Cancer Rats. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 2017;42:2330\u201341.","journal-title":"Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"key":"2275_CR115","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/17474124.2019.1595586","volume":"13","author":"G Al-Qadami","year":"2019","unstructured":"Al-Qadami G, Van Sebille Y, Le H, Bowen J. Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis. Expert Rev Gastroenterol Hepatol. 2019;13:485\u201396.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2275_CR116","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jamaoncol.2022.0494","volume":"8","author":"LS Liu","year":"2022","unstructured":"Liu LS, Shah K. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm. JAMA Oncol. 2022;8:1059\u201367.","journal-title":"JAMA Oncol"},{"key":"2275_CR117","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, et al. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 2017;170:548-563.e516.","journal-title":"Cell"},{"key":"2275_CR118","doi-asserted-by":"crossref","unstructured":"Zhang N, Kandalai S, Zhou X, Hossain F, Zheng Q. Applying multi-omics toward tumor microbiome research. iMeta. 2023;2:e73.","DOI":"10.1002\/imt2.73"},{"key":"2275_CR119","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41564-020-00831-6","volume":"6","author":"S-H Lee","year":"2021","unstructured":"Lee S-H, Cho S-Y, Yoon Y, Park C, Sohn J, Jeong J-J, Jeon B-N, Jang M, An C, Lee S, et al. Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice. Nat Microbiol. 2021;6:277\u201388.","journal-title":"Nat Microbiol"},{"key":"2275_CR120","first-page":"854","volume":"44","author":"B Eiseman","year":"1958","unstructured":"Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44:854\u20139.","journal-title":"Surgery"},{"key":"2275_CR121","doi-asserted-by":"publisher","first-page":"106633","DOI":"10.1016\/j.phrs.2022.106633","volume":"188","author":"S-L Zhang","year":"2023","unstructured":"Zhang S-L, Cheng L-S, Zhang Z-Y, Sun H-T, Li J-J. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer. Pharmacol Res. 2023;188:106633.","journal-title":"Pharmacol Res"},{"key":"2275_CR122","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","volume":"9","author":"Y Cao","year":"2024","unstructured":"Cao Y, Xia H, Tan X, Shi C, Ma Y, Meng D, Zhou M, Lv Z, Wang S, Jin Y. Intratumoural microbiota: a new frontier in cancer development and therapy. Signal Transduct Target Ther. 2024;9:15.","journal-title":"Signal Transduct Target Ther"},{"key":"2275_CR123","first-page":"2401","volume":"36","author":"BS Reddy","year":"1975","unstructured":"Reddy BS. Role of bile metabolites in colon carcinogenesis. Animal models. Cancer. 1975;36:2401\u20136.","journal-title":"Animal models Cancer"},{"key":"2275_CR124","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","volume":"461","author":"KM Maslowski","year":"2009","unstructured":"Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282\u20136.","journal-title":"Nature"},{"key":"2275_CR125","doi-asserted-by":"crossref","unstructured":"Rizvi ZA, Dalal R, Sadhu S, Kumar Y, Kumar S, Gupta SK, Tripathy MR, Rathore DK, Awasthi A. High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity. Science Advances. 2021;7:eabg5016.","DOI":"10.1126\/sciadv.abg5016"},{"key":"2275_CR126","doi-asserted-by":"crossref","unstructured":"Then CK, Paillas S, Moomin A, Misheva MD, Moir RA, Hay SM, Bremner D, Roberts Nee Nellany KS, Smith EE, Heidari Z, et al. Dietary fibre supplementation enhances radiotherapy tumour control and alleviates intestinal radiation toxicity. Microbiome. 2024;12:89.","DOI":"10.1186\/s40168-024-01804-1"},{"key":"2275_CR127","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1007\/BF00804826","volume":"84","author":"IG Bogdanov","year":"1977","unstructured":"Bogdanov IG, Velichkov VT, Gurevich AI, Dalev PG, Kolosov MN, Mal\u2019kova VP, Sorokina IB, Khristova LN. Antitumor action of glycopeptides from the cell wall of Lactobacillus bulgaricus. Bull Exp Biol Med. 1977;84:1750\u20133.","journal-title":"Bull Exp Biol Med"},{"key":"2275_CR128","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/carcin\/18.4.833","volume":"18","author":"J Singh","year":"1997","unstructured":"Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis. 1997;18:833\u201341.","journal-title":"Carcinogenesis"},{"key":"2275_CR129","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","volume":"118","author":"S Rakoff-Nahoum","year":"2004","unstructured":"Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229\u201341.","journal-title":"Cell"},{"key":"2275_CR130","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2005.05.007","volume":"122","author":"SK Mazmanian","year":"2005","unstructured":"Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122:107\u201318.","journal-title":"Cell"},{"key":"2275_CR131","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Li M, Chen Q, Li X, Chen L, Dong Z, Zhu W, Yang Y, Liu Z, Chen Q. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun. 2022;13:3432.","journal-title":"Nat Commun"},{"key":"2275_CR132","doi-asserted-by":"publisher","first-page":"e2202870","DOI":"10.1002\/adhm.202202870","volume":"12","author":"NA Siddiqui","year":"2023","unstructured":"Siddiqui NA, Ventrola AJ, Hartman AR, Konare T, Kamble NS, Thomas SC, Madaan T, Kharofa J, Sertorio MG, Kotagiri N. An Engineered Probiotic Platform for Cancer Epitope-Independent Targeted Radionuclide Therapy of Solid Tumors. Adv Healthc Mater. 2023;12:e2202870.","journal-title":"Adv Healthc Mater"},{"key":"2275_CR133","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0022-3565(25)29238-2","volume":"181","author":"MA Peppercorn","year":"1972","unstructured":"Peppercorn MA, Goldman P. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J Pharmacol Exp Ther. 1972;181:555\u201362.","journal-title":"J Pharmacol Exp Ther"},{"key":"2275_CR134","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1240537","volume":"342","author":"S Viaud","year":"2013","unstructured":"Viaud S, Saccheri F, Mignot G, Yamazaki T, Daill\u00e8re R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (New York, NY). 2013;342:971\u20136.","journal-title":"Science (New York, NY)"},{"key":"2275_CR135","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1158\/0008-5472.CAN-22-2593","volume":"83","author":"H Wu","year":"2023","unstructured":"Wu H, Leng X, Liu Q, Mao T, Jiang T, Liu Y, Li F, Cao C, Fan J, Chen L, et al. Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma. Can Res. 2023;83:3131\u201344.","journal-title":"Can Res"},{"key":"2275_CR136","doi-asserted-by":"crossref","unstructured":"D'Herelle F. On an invisible microbe antagonistic toward dysenteric bacilli: brief note by Mr. F. D'Herelle, presented by Mr. Roux. 1917. 2007;158:553\u2013554.","DOI":"10.1016\/j.resmic.2007.07.005"},{"key":"2275_CR137","first-page":"191","volume":"12","author":"M Kantoch","year":"1958","unstructured":"Kantoch M, Mordarski M. Binding of bacterial viruses by tumor cells in vitro. Postepy Higieny I Medycyny Doswiadczalnej. 1958;12:191\u20132.","journal-title":"Postepy Higieny I Medycyny Doswiadczalnej"},{"key":"2275_CR138","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1128\/AEM.72.4.3036-3041.2006","volume":"72","author":"M Duplessis","year":"2006","unstructured":"Duplessis M, L\u00e9vesque CM, Moineau S. Characterization of Streptococcus thermophilus host range phage mutants. Appl Environ Microbiol. 2006;72:3036\u201341.","journal-title":"Appl Environ Microbiol"},{"key":"2275_CR139","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41551-019-0423-2","volume":"3","author":"D-W Zheng","year":"2019","unstructured":"Zheng D-W, Dong X, Pan P, Chen K-W, Fan J-X, Cheng S-X, Zhang X-Z. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy. Nature Biomedical Engineering. 2019;3:717\u201328.","journal-title":"Nature Biomedical Engineering"},{"key":"2275_CR140","doi-asserted-by":"crossref","unstructured":"Dong X, Pan P, Zheng D-W, Bao P, Zeng X, Zhang X-Z. Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer. Science Advances. 2020;6:eaba1590.","DOI":"10.1126\/sciadv.aba1590"},{"key":"2275_CR141","doi-asserted-by":"crossref","unstructured":"Gencay YE, Jasinskyt\u0117 D, Robert C, Semsey S, Mart\u00ednez V, Petersen A\u00d8, Brunner K, de Santiago Torio A, Salazar A, Turcu IC, et al. Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice. Nature Biotechnology. 2024;42:265\u2013274.","DOI":"10.1038\/s41587-023-01759-y"},{"key":"2275_CR142","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1073\/pnas.70.11.3240","volume":"70","author":"SN Cohen","year":"1973","unstructured":"Cohen SN, Chang AC, Boyer HW, Helling RB. Construction of biologically functional bacterial plasmids in vitro. Proc Natl Acad Sci USA. 1973;70:3240\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2275_CR143","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nm0595-471","volume":"1","author":"ZK Pan","year":"1995","unstructured":"Pan ZK, Ikonomidis G, Lazenby A, Pardoll D, Paterson Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat Med. 1995;1:471\u20137.","journal-title":"Nat Med"},{"key":"2275_CR144","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1038\/s41467-022-35130-7","volume":"13","author":"J Zhu","year":"2022","unstructured":"Zhu J, Ke Y, Liu Q, Yang J, Liu F, Xu R, Zhou H, Chen A, Xiao J, Meng F, et al. Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy. Nat Commun. 2022;13:7466.","journal-title":"Nat Commun"},{"key":"2275_CR145","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s43018-025-00932-3","volume":"6","author":"L Qiao","year":"2025","unstructured":"Qiao L, Niu L, Wang Z, Deng Z, Di D, Ma X, Zhou Y, Kong D, Wang Q, Yin J, et al. Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics. Nature Cancer. 2025;6:612\u201328.","journal-title":"Nature Cancer"},{"key":"2275_CR146","first-page":"6387","volume":"46","author":"Y Matsumura","year":"1986","unstructured":"Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387\u201392.","journal-title":"Cancer Res"},{"key":"2275_CR147","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3109\/10611860108998768","volume":"9","author":"M Kabbaj","year":"2001","unstructured":"Kabbaj M, Phillips NC. Anticancer activity of mycobacterial DNA: effect of formulation as chitosan nanoparticles. J Drug Target. 2001;9:317\u201328.","journal-title":"J Drug Target"},{"key":"2275_CR148","doi-asserted-by":"publisher","first-page":"2407685","DOI":"10.1002\/adfm.202407685","volume":"34","author":"R Zhu","year":"2024","unstructured":"Zhu R, Yuan W, Xia A, Sun X, Yan W, Wu T, Wang G, Li Y, Yin Q, Li Y. Inulin-Based Nanoparticle Modulates Gut Microbiota and Immune Microenvironment for Improving Colorectal Cancer Therapy. Adv Funct Mater. 2024;34:2407685.","journal-title":"Adv Funct Mater"},{"key":"2275_CR149","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41467-025-56498-2","volume":"16","author":"Y Teng","year":"2025","unstructured":"Teng Y, Luo C, Qiu X, Mu J, Sriwastva MK, Xu Q, Liu M, Hu X, Xu F, Zhang L, et al. Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites. Nat Commun. 2025;16:1295.","journal-title":"Nat Commun"},{"key":"2275_CR150","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.aaz7015","volume":"374","author":"CN Spencer","year":"2021","unstructured":"Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, Khan MAW, Zhang X, White MG, Peterson CB, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science (New York, NY). 2021;374:1632\u201340.","journal-title":"Science (New York, NY)"},{"issue":"e145207","key":"2275_CR151","doi-asserted-by":"publisher","first-page":"145207","DOI":"10.1172\/jci.insight.145207","volume":"6","author":"G Ferrere","year":"2021","unstructured":"Ferrere G, Tidjani Alou M, Liu P, Goubet A-G, Fidelle M, Kepp O, Durand S, Iebba V, Fluckiger A, Daill\u00e8re R, et al. Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade. JCI insight. 2021;6(e145207):145207.","journal-title":"JCI insight"},{"key":"2275_CR152","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.clnu.2024.03.018","volume":"43","author":"F Bozzetti","year":"2024","unstructured":"Bozzetti F. The role of the nutrition in malnourished cancer patients: Revisiting an old dilemma. Clinical Nutrition (Edinburgh, Scotland). 2024;43:1320\u20138.","journal-title":"Clinical Nutrition (Edinburgh, Scotland)"},{"key":"2275_CR153","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1038\/s41388-020-1341-1","volume":"39","author":"W Fong","year":"2020","unstructured":"Fong W, Li Q, Yu J. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Oncogene. 2020;39:4925.","journal-title":"Oncogene"},{"key":"2275_CR154","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.chom.2021.08.001","volume":"29","author":"A Montalban-Arques","year":"2021","unstructured":"Montalban-Arques A, Katkeviciute E, Busenhart P, Bircher A, Wirbel J, Zeller G, Morsy Y, Borsig L, Glaus Garzon JF, M\u00fcller A, et al. Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors. Cell Host Microbe. 2021;29:1573-1588.e1577.","journal-title":"Cell Host Microbe"},{"key":"2275_CR155","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods8030092","volume":"8","author":"D Davani-Davari","year":"2019","unstructured":"Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, Berenjian A, Ghasemi Y. Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods. 2019;8:92.","journal-title":"Foods"},{"key":"2275_CR156","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.7150\/thno.54476","volume":"11","author":"S-L Zhang","year":"2021","unstructured":"Zhang S-L, Mao Y-Q, Zhang Z-Y, Li Z-M, Kong C-Y, Chen H-L, Cai P-R, Han B, Ye T, Wang L-S. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer. Theranostics. 2021;11:4155\u201370.","journal-title":"Theranostics"},{"key":"2275_CR157","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41551-021-00749-2","volume":"5","author":"K Han","year":"2021","unstructured":"Han K, Nam J, Xu J, Sun X, Huang X, Animasahun O, Achreja A, Jeon JH, Pursley B, Kamada N, et al. Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel. Nature Biomedical Engineering. 2021;5:1377\u201388.","journal-title":"Nature Biomedical Engineering"},{"key":"2275_CR158","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clnu.2015.11.008","volume":"36","author":"M Motoori","year":"2017","unstructured":"Motoori M, Yano M, Miyata H, Sugimura K, Saito T, Omori T, Fujiwara Y, Miyoshi N, Akita H, Gotoh K, et al. Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients. Clinical Nutrition (Edinburgh, Scotland). 2017;36:93\u20139.","journal-title":"Clinical Nutrition (Edinburgh, Scotland)"},{"key":"2275_CR159","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5946\/ce.2019.009","volume":"52","author":"KO Kim","year":"2019","unstructured":"Kim KO, Gluck M. Fecal Microbiota Transplantation: An Update on Clinical Practice. Clinical Endoscopy. 2019;52:137.","journal-title":"Clinical Endoscopy"},{"key":"2275_CR160","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1126\/science.aaq0034","volume":"358","author":"D Hoffmann","year":"2017","unstructured":"Hoffmann D, Palumbo F, Ravel J, Roghmann M-C, Rowthorn V, von Rosenvinge E. Improving regulation of microbiota transplants. Science. 2017;358:1390\u20131.","journal-title":"Science"},{"key":"2275_CR161","doi-asserted-by":"publisher","first-page":"e00060","DOI":"10.1128\/cmr.00060-22","volume":"37","author":"A Yadegar","year":"2024","unstructured":"Yadegar A, Bar-Yoseph H, Monaghan TM, Pakpour S, Severino A, Kuijper EJ, Smits WK, Terveer EM, Neupane S, Nabavi-Rad A, et al. Fecal microbiota transplantation: current challenges and future landscapes. Clin Microbiol Rev. 2024;37:e00060-e22.","journal-title":"Clin Microbiol Rev"},{"key":"2275_CR162","doi-asserted-by":"crossref","unstructured":"Lopetuso LR, Deleu S, Puca P, Abreu MT, Armuzzi A, Barbara G, Caprioli F, Chieng S, Costello SP, Damiani A, et al. Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference. Inflamm Bowel Dis. 2025;izaf013. Advance online publicaton.","DOI":"10.1093\/ibd\/izaf013"},{"key":"2275_CR163","doi-asserted-by":"crossref","unstructured":"Cieplak T, Soffer N, Sulakvelidze A, Nielsen DS. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota. Gut Microbes. 2018;9:391\u2013399.","DOI":"10.1080\/19490976.2018.1447291"},{"key":"2275_CR164","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.7150\/ijms.6960","volume":"10","author":"G-f Guan","year":"2013","unstructured":"Guan G-f. Zhao M, Liu L-m, Jin C-s, Sun K, Zhang D-j, Yu D-j, Cao H-w, Lu Y-q, Wen L-j. Salmonella typhimurium mediated delivery of Apoptin in human laryngeal cancer. Int J Med Sci. 2013;10:1639\u201348.","journal-title":"Int J Med Sci"},{"key":"2275_CR165","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nature18930","volume":"536","author":"MO Din","year":"2016","unstructured":"Din MO, Danino T, Prindle A, Skalak M, Selimkhanov J, Allen K, Julio E, Atolia E, Tsimring LS, Bhatia SN, Hasty J. Synchronized cycles of bacterial lysis for in vivo delivery. Nature. 2016;536:81\u20135.","journal-title":"Nature"},{"key":"2275_CR166","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.addr.2022.114364","volume":"187","author":"HS Shen","year":"2022","unstructured":"Shen HS, Aggarwal N, Wun KS, Lee YS, Hwang IY, Chang MW. Engineered microbial systems for advanced drug delivery. Adv Drug Deliv Rev. 2022;187:15.","journal-title":"Adv Drug Deliv Rev"},{"key":"2275_CR167","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1021\/acssynbio.6b00256","volume":"5","author":"BL Adams","year":"2016","unstructured":"Adams BL. The Next Generation of Synthetic Biology Chassis: Moving Synthetic Biology from the Laboratory to the Field. ACS Synth Biol. 2016;5:1328\u201330.","journal-title":"ACS Synth Biol"},{"key":"2275_CR168","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","volume":"598","author":"FP Canale","year":"2021","unstructured":"Canale FP, Basso C, Antonini G, Perotti M, Li N, Sokolovska A, Neumann J, James MJ, Geiger S, Jin W, et al. Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature. 2021;598:662\u20136.","journal-title":"Nature"},{"key":"2275_CR169","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41585-021-00481-1","volume":"18","author":"N Lobo","year":"2021","unstructured":"Lobo N, Brooks NA, Zlotta AR, Cirillo JD, Boorjian S, Black PC, Meeks JJ, Bivalacqua TJ, Gontero P, Steinberg GD, et al. 100 years of Bacillus Calmette-Gu\u00e9rin immunotherapy: from cattle to COVID-19. Nat Rev Urol. 2021;18:611\u201322.","journal-title":"Nat Rev Urol"},{"key":"2275_CR170","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","volume":"635","author":"A Redenti","year":"2024","unstructured":"Redenti A, Im J, Redenti B, Li F, Rouanne M, Sheng Z, Sun W, Gurbatri CR, Huang S, Komaranchath M, et al. Probiotic neoantigen delivery vectors for precision cancer immunotherapy. Nature. 2024;635:453\u201361.","journal-title":"Nature"},{"key":"2275_CR171","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.addr.2017.04.008","volume":"114","author":"JEV Ramirez","year":"2017","unstructured":"Ramirez JEV, Sharpe LA, Peppas NA. Current state and challenges in developing oral vaccines. Adv Drug Deliv Rev. 2017;114:116\u201331.","journal-title":"Adv Drug Deliv Rev"},{"key":"2275_CR172","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/jpm11060571","volume":"11","author":"MA Subhan","year":"2021","unstructured":"Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP. Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment. J Personalized Med. 2021;11:571.","journal-title":"J Personalized Med"},{"key":"2275_CR173","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jconrel.2024.07.045","volume":"373","author":"A Cern","year":"2024","unstructured":"Cern A, Skoczen SL, Snapp KS, Hod A, Zilbersheid D, Bavli Y, Alon-Maimon T, Bachrach G, Wei X, Berman B, et al. Nano-mupirocin as tumor-targeted antibiotic: Physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome. Journal of Controlled Release: Official Journal of the Controlled Release Society. 2024;373:713\u201326.","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"key":"2275_CR174","doi-asserted-by":"publisher","first-page":"e1805007","DOI":"10.1002\/adma.201805007","volume":"30","author":"W Song","year":"2018","unstructured":"Song W, Tiruthani K, Wang Y, Shen L, Hu M, Dorosheva O, Qiu K, Kinghorn KA, Liu R, Huang L. Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis. Advanced Materials (Deerfield Beach, Fla). 2018;30:e1805007.","journal-title":"Advanced Materials (Deerfield Beach, Fla)"},{"key":"2275_CR175","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41579-018-0112-2","volume":"17","author":"M Toyofuku","year":"2019","unstructured":"Toyofuku M, Nomura N, Eberl L. Types and origins of bacterial membrane vesicles. Nat Rev Microbiol. 2019;17:13\u201324.","journal-title":"Nat Rev Microbiol"},{"key":"2275_CR176","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri3837","volume":"15","author":"M Kaparakis-Liaskos","year":"2015","unstructured":"Kaparakis-Liaskos M, Ferrero RL. Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol. 2015;15:375\u201387.","journal-title":"Nat Rev Immunol"},{"key":"2275_CR177","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jconrel.2020.04.031","volume":"323","author":"M Li","year":"2020","unstructured":"Li M, Zhou H, Yang C, Wu Y, Zhou X, Liu H, Wang Y. Bacterial outer membrane vesicles as a platform for biomedical applications: An update. J Control Release. 2020;323:253\u201368.","journal-title":"J Control Release"},{"key":"2275_CR178","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1039\/D4FO04790G","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhang Y, Dai M, Qiu C, Sun Q, Fan T, Guo Y, Zhao L, Jiang Y. \u03b3-Linolenic acid derived from Lactobacillus plantarum MM89 induces ferroptosis in colorectal cancer. Food Funct. 2025;16:1760\u201371.","journal-title":"Food Funct"},{"issue":"1524","key":"2275_CR179","first-page":"00734","volume":"S1534\u20135807","author":"M Wang","year":"2025","unstructured":"Wang M, Liu K, Bao W, Hang B, Chen X, Zhu X, Li G, Liu L, Xiang H, Hu H, et al. Gut microbiota protect against colorectal tumorigenesis through lncRNA Snhg9. Dev Cell. 2025;S1534\u20135807(1524):00734\u2013732.","journal-title":"Dev Cell"},{"key":"2275_CR180","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s11427-024-2831-x","volume":"68","author":"R Zhang","year":"2024","unstructured":"Zhang R, Zhang X, Lau HCH, Yu J. Gut microbiota in cancer initiation, development and therapy. Sci China Life Sci. 2024;68:1283\u2013308.","journal-title":"Sci China Life Sci"},{"key":"2275_CR181","doi-asserted-by":"publisher","first-page":"e70115","DOI":"10.1111\/1751-7915.70115","volume":"18","author":"Y Wang","year":"2025","unstructured":"Wang Y, Qiu X, Chu A, Chen J, Wang L, Sun X, Wang B, Yuan Y, Gong Y. Advances in 16S rRNA-Based Microbial Biomarkers for Gastric Cancer Diagnosis and Prognosis. Microb Biotechnol. 2025;18:e70115.","journal-title":"Microb Biotechnol"},{"key":"2275_CR182","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s40265-022-01797-x","volume":"82","author":"S Khanna","year":"2022","unstructured":"Khanna S, Assi M, Lee C, Yoho D, Louie T, Knapple W, Aguilar H, Garcia-Diaz J, Wang GP, Berry SM, et al. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection. Drugs. 2022;82:1527\u201338.","journal-title":"Drugs"},{"key":"2275_CR183","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1056\/NEJMoa2106516","volume":"386","author":"P Feuerstadt","year":"2022","unstructured":"Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, Sims M, Kraft CS, Cohen SH, Berenson CS, et al. SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med. 2022;386:220\u20139.","journal-title":"N Engl J Med"},{"key":"2275_CR184","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41586-024-07681-w","volume":"632","author":"AK Br\u00f6del","year":"2024","unstructured":"Br\u00f6del AK, Charpenay LH, Galtier M, Fuche FJ, Terrasse R, Poquet C, Havr\u00e1nek J, Pignotti S, Krawczyk A, Arraou M, et al. In situ targeted base editing of bacteria in the mouse gut. Nature. 2024;632:877\u201384.","journal-title":"Nature"},{"key":"2275_CR185","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12934-022-01920-3","volume":"21","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Yu Z, Wang J, Yu Y, Li L, Sun P, Fan X, Xu Q. Metabolic engineering of Escherichia coli for efficient production of L-5-hydroxytryptophan from glucose. Microb Cell Fact. 2022;21:198.","journal-title":"Microb Cell Fact"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02275-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02275-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02275-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T06:03:15Z","timestamp":1749103395000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02275-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":185,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2275"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02275-z","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}